A description of the costs of living and standard criteria deceased donor kidney transplantation

American Journal of Transplantation

Volumn 11, Issue 3, 2011, Pages 478-488

  Barnieh, L ^a   Manns, B J ^a,b   Klarenbach, S ^c   McLaughlin, K ^b   Yilmaz, S ^a   Hemmelgarn, Brenda R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cost analysis; Deceased donation; Kidney transplantation; Living donation

Indexed keywords

ADULT; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF LIVING; DECISION MAKING; DIAGNOSTIC IMAGING; FEMALE; GRAFT RECIPIENT; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; KIDNEY TRANSPLANTATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; CADAVER; FEMALE; HEALTH CARE COSTS; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RENAL DIALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79951978789     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03425.x     Document Type: Article

References (33)

1. Landreneau K, Lee K, Landreneau M. Quality of life in patients undergoing hemodialysis and renal transplantation - A meta-analytic review. Nephrol Nurs J 2010; 37: 37-45.
2. Laupacis A, Keown P, Pus N et al. A study on the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242. (Pubitemid 26323718)
3. De Wit G, Ramsteijn P, de Charro F. Economic evaluation of end stage renal disease treatment. Health Policy 1998; 44: 215-232. (Pubitemid 28345184)
4. Matas A, Gillingham K, Humar A et al. 2202 kidney transplant recipients with 10 years of graft function: What happens next? Am J Transplant 2008; 8: 2410-2419.
5. Canadian Institute for Health Information. Organ donor activity in Canada, 1999 to 2008, Ottawa: CIHI2009.
6. Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000; 343: 404-410. (Pubitemid 30626124)
7. Gill J, Klarenbach S, Cole E, Shemie S. Deceased organ donation in Canada: An opportunity to heal a fractured system. Am J Transplant 2008; 8: 1580-1587.
8. Arend S, et al. Patient survival after renal transplantation: More than 25 years follow-up. Nephrol Dial Transplant 1997; 12: 1672.
9. Eggers P, Kucken L. Cost issues in transplantation. Surg Clin North Am 1994; 74: 1259-1267. (Pubitemid 24314159)
10. Pace K, Dyer S, Phan V et al. Laparoscopic v open donor nephrectomy: A cost-utility analysis of the initial experience at a tertiarycare center. J Endourol 2002; 16: 495-510.
11. Levy A, Sobolev B, James D et al. The costs of change: Direct medical costs of solid organ transplantation in British Columbia, Canada, 1995-2003. Value Health 2008; 12: 282-292.
12. Howard K, Salkeld G, White S et al. The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology 2009; 14: 123-132.
13. Erek E, Sever M, Akoglu E et al. Cost of renal replacement therapy in Turkey. Nephrology 2004; 9: 33-38. (Pubitemid 38230530)
14. Mullins C, Thomas S, Pradel F, Bartlett S. The economic impact of laparoscopic living-donor nephrectomy on kidney transplantation. Transplantation 2003; 75: 1505-1512. (Pubitemid 36597286)
15. Smith C, Woodward R, Cohen D et al. Cadaveric versus living donor kidney transplantation: AMedicare payment analysis. Transplantation 2000; 69: 311-314. (Pubitemid 30075293)
16. Knoll G. Trends in kidney transplantation over the past decade. Drugs 2008; 68(Suppl 1): 3-10. (Pubitemid 351601432)
17. Roodnat J, Kal-van Gestel J, Zuidema W et al. Successful expansion of the living donor pool by alternative living donation programs. Am J Transplant 2009; 9: 2150-2156.
18. Matas A. Should we pay donors to increase the supply of organs for transplantation? BMJ 2008; 336: 1342-1343.
19. Sickand M, Cuerden M, Klarenbach S et al. Reimbursing live organ donors for incurred non-medical expenses: A global perspective on policies and programs. Am J Transplant 2009; 9: 2825-2836.
20. Hippen B, Matas A. Incentives for organ donation in the United States: Feasible alternative or forthcoming apocalypse? Curr Opin Organ Transpl 2009; 14: 140-146.
21. Peters T, Repper S, Vincent M et al. One hundred consecutive living kidney donors: Modern issues and outcomes. Clin Transplant 2002; 16: 62-68. (Pubitemid 41185588)
22. Canadian Organ Replacement Register, CORR Annual Reports, 2007. Ottawa: Canadian Institute for Health Information, 2007.
23. Manns B, Lee H, Taub K et al. Cost analysis of ongoing care of patients with end-stage renal disease: What are the important determinants? Edmonton, AB: Alberta Centre for Health Services Utilization Research, 2003.
24. Badovinac K, Greig P, Ross H, Doig C, Shemie S. Organ utilization among deceased donors in Canada, 1993-2002. Can J Anaesth 2006; 53: 838-844.
25. Drummond M, Sculpher M, Torrance G, O'Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. 3rd Ed. Oxford: Oxford University Press, 2006.
26. Lee H, Manns B, Taub K et al. Cost analysis of ongoing care of patientswith end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40: 611-622. (Pubitemid 34971291)
27. Manns B, Tonelli M, Yilmaz S et al. Establishment and maintenance of vascular access in incident hemodialysis patients: A prospective cost analysis. J Am Soc Nephrol 2005; 16: 201-209. (Pubitemid 43073174)
28. Canadian Institute for Health Information. Guidelines for management information systems in Canadian health service organizations, Ottawa: Canadian Institute for Health Information, 1999.
29. Manns B, Mortis G, Taub K et al. The southern Alberta renal program database: A prototype for patient management and research initiatives. Clin Invest Med 2001; 24: 164-170. (Pubitemid 32912362)
30. McKillop I. A Research Project to Examine the Costing Methodologies Recommended in the MIS Guidelines, Ottawa: Canadian Institute for Health Information, 1995.
31. McKillop I, Pink G, Johnson L. The financial management of acute care in Canada: A review of funding, performance monitoring, and reporting practices, Ottawa: Canadian Institutes for Health Information, 2001.
32. Clement F, Ghali W, Donaldson C, Manns B. The impact of using different costingmethods on the results of an economic evaluation of cardiac care: Microcosting vs gross-costing approaches. Health Econ 2009; 18: 377-388.
33. Canadian Institute for Health Information. Treatment of End-Stage Organ Failure in Canada, 1999 to 2008 - CORR 2010 Annual Report. Ottawa, Ontario: CIHI2010.